Masimo Corp. (MASI)
130.06
-1.01
(-0.77%)
USD |
NASDAQ |
Dec 31, 16:00
130.05
-0.01
(-0.01%)
Pre-Market: 20:00
Masimo Cash from Investing (Quarterly): 282.30M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -15.59M |
| West Pharmaceutical Services, Inc. | -63.30M |
| Insulet Corp. | -31.00M |
| UFP Technologies, Inc. | -15.27M |
| Clearpoint Neuro, Inc. | -0.199M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 56.80M |
| Cash from Financing (Quarterly) | -218.40M |
| Free Cash Flow | 188.70M |
| Free Cash Flow Per Share (Quarterly) | 0.9136 |
| Free Cash Flow to Equity (Quarterly) | 105.70M |
| Free Cash Flow to Firm (Quarterly) | 56.01M |
| Free Cash Flow Yield | 2.68% |